An argument in favor of this latter mechanism is offered by the HLA-DRB1*13 allele, which is suspected to confer a protective role against six autoimmune diseases, including MG, by an optimization of the T cells’ negative selection [46]. This evidence concerns the gene HLA-DRB1 and myasthenia gravis.